• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凋亡逃避:生存途径在前列腺癌进展和治疗抗性中的作用

Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance.

作者信息

McKenzie Shaun, Kyprianou Natasha

机构信息

Department of Surgery/Urology, University of Kentucky Medical Center, Lexington, KY, USA.

出版信息

J Cell Biochem. 2006 Jan 1;97(1):18-32. doi: 10.1002/jcb.20634.

DOI:10.1002/jcb.20634
PMID:16216007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2274918/
Abstract

The ability of a tumor cell population to grow exponentially represents an imbalance between cellular proliferation and cellular attrition. There is an overwhelming body of evidence suggesting the ability of tumor cells to avoid programmed cellular attrition, or apoptosis, is a major molecular force driving the progression of human tumors. Apoptotic evasion represents one of the true hallmarks of cancer and appears to be a vital component in the immunogenic, chemotherapeutic, and radiotherapeutic resistance that characterizes the most aggressive of human cancers [Hanahan and Weinberg, 2000]. The challenges in the development of effective treatment modalities for advanced prostate cancer represent a classic paradigm of the functional significance of anti-apoptotic pathways in the development of therapeutic resistance.

摘要

肿瘤细胞群体呈指数增长的能力代表了细胞增殖与细胞损耗之间的失衡。大量证据表明,肿瘤细胞避免程序性细胞损耗即凋亡的能力是推动人类肿瘤进展的主要分子力量。凋亡逃避是癌症的真正标志之一,并且似乎是最具侵袭性的人类癌症所具有的免疫原性、化疗和放疗抗性的重要组成部分[哈纳汉和温伯格,2000年]。晚期前列腺癌有效治疗方式研发面临的挑战代表了抗凋亡途径在治疗抗性发展中的功能意义的经典范例。

相似文献

1
Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance.凋亡逃避:生存途径在前列腺癌进展和治疗抗性中的作用
J Cell Biochem. 2006 Jan 1;97(1):18-32. doi: 10.1002/jcb.20634.
2
Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer.程序性(凋亡)细胞死亡在前列腺癌进展和治疗过程中的作用。
Prostate. 1996 Apr;28(4):251-65. doi: 10.1002/(SICI)1097-0045(199604)28:4<251::AID-PROS6>3.0.CO;2-G.
3
Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting.前列腺生长中的生长因子信号传导:在肿瘤发展及治疗靶向中的意义
Br J Pharmacol. 2006 Feb;147 Suppl 2(Suppl 2):S144-52. doi: 10.1038/sj.bjp.0706635.
4
Cell death under epithelial-mesenchymal transition control in prostate cancer therapeutic response.前列腺癌治疗反应中上皮-间质转化控制下的细胞死亡
Int J Urol. 2018 Apr;25(4):318-326. doi: 10.1111/iju.13505. Epub 2018 Jan 17.
5
Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer.性类固醇诱导的细胞凋亡作为治疗抗激素耐药性乳腺癌和前列腺癌的合理策略。
Discov Med. 2016 May;21(117):411-27.
6
Target to apoptosis: a hopeful weapon for prostate cancer.靶向凋亡:前列腺癌的一种有望的武器。
Prostate. 1997 Sep 1;32(4):284-93. doi: 10.1002/(sici)1097-0045(19970901)32:4<284::aid-pros9>3.0.co;2-j.
7
Radiation-induced apoptosis: predictive and therapeutic significance in radiotherapy of prostate cancer (review).辐射诱导的细胞凋亡:在前列腺癌放射治疗中的预测及治疗意义(综述)
Oncol Rep. 2000 Jul-Aug;7(4):699-706. doi: 10.3892/or.7.4.699.
8
Targeting anoikis resistance in prostate cancer metastasis.靶向前列腺癌转移中的抗失巢凋亡。
Mol Aspects Med. 2010 Apr;31(2):205-14. doi: 10.1016/j.mam.2010.02.001. Epub 2010 Feb 11.
9
Sequencing hormonal ablation and radiotherapy in prostate cancer: a molecular and therapeutic prespective (Review).前列腺癌中激素消融与放疗的序贯治疗:分子与治疗学视角(综述)
Oncol Rep. 2002 Nov-Dec;9(6):1151-6.
10
Mechanisms of apoptosis resistance and treatment strategies to overcome them in hormone-refractory prostate cancer.激素难治性前列腺癌中凋亡抵抗的机制及克服这些机制的治疗策略。
Cancer. 2008 Apr 15;112(8):1660-71. doi: 10.1002/cncr.23318.

引用本文的文献

1
S-Methyl Methanethiosulfonate, the Main Human Metabolite of S-Methyl-L-Cysteine Sulfoxide, Alters Energy Metabolism in Prostate Cancer Cells.S-甲基甲硫基磺酸盐,S-甲基-L-半胱氨酸亚砜的主要人体代谢产物,改变前列腺癌细胞的能量代谢。
Mol Nutr Food Res. 2025 Apr;69(8):e70008. doi: 10.1002/mnfr.70008. Epub 2025 Mar 9.
2
8-Br-cGMP activates HSPB6 and increases the antineoplastic activity of quinidine in prostate cancer.8-溴环磷酸鸟苷激活HSPB6并增强奎尼丁在前列腺癌中的抗肿瘤活性。
Cell Death Discov. 2024 Feb 19;10(1):90. doi: 10.1038/s41420-024-01853-3.
3
Flavones: The Apoptosis in Prostate Cancer of Three Flavones Selected as Therapeutic Candidate Models.

本文引用的文献

1
The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480.转移性激素难治性前列腺癌患者血浆白细胞介素-6水平的预后意义:癌症与白血病B组9480研究结果
Clin Cancer Res. 2005 Mar 1;11(5):1815-20. doi: 10.1158/1078-0432.CCR-04-1560.
2
Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor.成骨细胞通过白细胞介素-6介导的雄激素受体激活诱导前列腺癌增殖和前列腺特异性抗原表达。
Clin Exp Metastasis. 2004;21(5):399-408. doi: 10.1007/s10585-005-0056-6.
3
类黄酮:三种类黄酮作为治疗候选模型在前列腺癌中的细胞凋亡作用。
Int J Mol Sci. 2023 May 25;24(11):9240. doi: 10.3390/ijms24119240.
4
Anoikis in phenotypic reprogramming of the prostate tumor microenvironment.细胞失巢凋亡在前列腺肿瘤微环境表型重编程中的作用。
Front Endocrinol (Lausanne). 2023 Apr 5;14:1160267. doi: 10.3389/fendo.2023.1160267. eCollection 2023.
5
Androgen receptor signaling-mitochondrial DNA-oxidative phosphorylation: A critical triangle in early prostate cancer.雄激素受体信号传导-线粒体DNA-氧化磷酸化:早期前列腺癌中的关键三角关系
Curr Urol. 2022 Dec;16(4):207-212. doi: 10.1097/CU9.0000000000000120. Epub 2022 Aug 31.
6
The E3 Ligase TRIM25 Impairs Apoptotic Cell Death in Colon Carcinoma Cells via Destabilization of Caspase-7 mRNA: A Possible Role of hnRNPH1.E3 连接酶 TRIM25 通过 Caspase-7 mRNA 的不稳定性抑制结肠癌细胞中的细胞凋亡死亡:hnRNPH1 的可能作用。
Cells. 2023 Jan 3;12(1):201. doi: 10.3390/cells12010201.
7
Molecular and metabolic alterations of 2,3-dihydroquinazolin-4(1H)-one derivatives in prostate cancer cell lines.2,3-二氢喹唑啉-4(1H)-酮衍生物在前列腺癌细胞系中的分子和代谢改变。
Sci Rep. 2022 Dec 14;12(1):21599. doi: 10.1038/s41598-022-26148-4.
8
Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications.前列腺癌细胞系在超分割低剂量分割体外放射治疗中存活的放射抵抗机制:意义及可能的临床应用
Cancers (Basel). 2022 Nov 9;14(22):5504. doi: 10.3390/cancers14225504.
9
2-Methoxy-estradiol Loaded Alpha Lipoic Acid Nanoparticles Augment Cytotoxicity in MCF-7 Breast Cancer Cells.负载2-甲氧基雌二醇的α-硫辛酸纳米颗粒增强MCF-7乳腺癌细胞的细胞毒性。
Dose Response. 2021 Dec 9;19(4):15593258211055023. doi: 10.1177/15593258211055023. eCollection 2021 Oct-Dec.
10
Development, Optimization and Evaluation of 2-Methoxy-Estradiol Loaded Nanocarrier for Prostate Cancer.用于前列腺癌的载2-甲氧基雌二醇纳米载体的研发、优化及评估
Front Pharmacol. 2021 Jul 16;12:682337. doi: 10.3389/fphar.2021.682337. eCollection 2021.
Cancer statistics, 2005.
2005年癌症统计数据。
CA Cancer J Clin. 2005 Jan-Feb;55(1):10-30. doi: 10.3322/canjclin.55.1.10.
4
Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.核因子-κB(NF-κB)和抑制蛋白κB(IκB)蛋白的磷酸化:对癌症和炎症的影响
Trends Biochem Sci. 2005 Jan;30(1):43-52. doi: 10.1016/j.tibs.2004.11.009.
5
Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.前列腺癌进展的分子见解:肿瘤微环境的缺失环节
J Urol. 2005 Jan;173(1):10-20. doi: 10.1097/01.ju.0000141582.15218.10.
6
Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model.在一种谱系衍生的前列腺癌进展模型中,胰岛素样生长因子I受体表达增加和信号传导增强是雄激素非依赖性进展的组成部分。
Cancer Res. 2004 Dec 1;64(23):8620-9. doi: 10.1158/0008-5472.CAN-04-2446.
7
Racial disparity of epidermal growth factor receptor expression in prostate cancer.前列腺癌中表皮生长因子受体表达的种族差异
J Clin Oncol. 2004 Dec 1;22(23):4725-9. doi: 10.1200/JCO.2004.06.134.
8
Cyclooxygenase-2 suppresses hypoxia-induced apoptosis via a combination of direct and indirect inhibition of p53 activity in a human prostate cancer cell line.在人前列腺癌细胞系中,环氧化酶-2通过直接和间接抑制p53活性的组合方式抑制缺氧诱导的细胞凋亡。
J Biol Chem. 2005 Feb 4;280(5):3817-23. doi: 10.1074/jbc.M406577200. Epub 2004 Nov 18.
9
Endogenous inhibitors of nuclear factor-kappaB, an opportunity for cancer control.核因子-κB的内源性抑制剂:癌症控制的契机
Cancer Res. 2004 Nov 15;64(22):8135-8. doi: 10.1158/0008-5472.CAN-04-2096.
10
HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability.HER2/neu激酶通过影响DNA结合和稳定性对雄激素受体功能进行依赖性调节。
Cancer Cell. 2004 Nov;6(5):517-27. doi: 10.1016/j.ccr.2004.09.031.